DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Cristino J, Finek J, Jandova P. et al
Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic.
J Med Econ 2017;
20 (08) 799-812
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.